Growth arrest-specific protein 6 attenuates neutrophil migration and acute lung injury in sepsis

Shock

Volumn 40, Issue 6, 2013, Pages 485-491

  Giangola, Matthew D ^a   Yang, Weng Lang ^a,b   Rajayer, Salil R ^b   Nicastro, Jeffrey ^a   Coppa, Gene F ^a   Wang, Ping ^a,b  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

acute lung injury; Gas6; inflammation; neutrophil; sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GROWTH ARREST SPECIFIC PROTEIN 6; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MYELOPEROXIDASE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL MIGRATION; CELL STRAIN HL 60; DISEASE SEVERITY; DRUG EFFICACY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIGATION; LUNG INJURY; LUNG PARENCHYMA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; PUNCTURE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SURVIVAL RATE; TREATMENT DURATION;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CELLS, CULTURED; CHEMOKINES; CYTOKINES; DRUG EVALUATION, PRECLINICAL; I-KAPPA B PROTEINS; IMMUNE SYSTEM DISEASES; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTE DISORDERS; LUNG; MALE; MICE; PEROXIDASE; RECOMBINANT PROTEINS; SEPSIS;

EID: 84888129033     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182a588c1     Document Type: Article

References (35)

1. Gaieski DF, Edwards M, Kallan M, Carr BG: Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 41:1167-1174, 2013.
2. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554, 2003.
3. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med 353:1685-1693, 2005.
4. Matthay MA, Zimmerman GA: Acute lung injury and the acute respiratory distress syndrome. Am J Respir Cell Mol Biol 33:319-327, 2005.
5. Moine P, McIntyre R, Schwartz MD, Kaneko D, Shenkar R, Le Tulzo Y, Moore EE, Abraham E: NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 13:85-91, 2000.
6. Liu SF, Malik AB: NF-. B activation as a pathologic mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290:L622YL645, 2006.
7. Abraham E: Neutrophils and acute lung injury. Crit Care Med 31(Suppl): S195YS199, 2003.
8. Aziz M, Matsuda A, Yang WL, Jacob A, Wang P: Milk fat globule-epidermal growth factor-factor 8 attenuates neutrophil infiltration in acute lung injury via modulation of CXCR2. J Immunol 189:393-402, 2012.
9. Lee WL, Downey GP: Neutrophil activation and acute lung injury. Curr Opin Crit Care 7:1-7, 2001.
10. Grommes J, Soehnlein O: Contribution of neutrophils to acute lung injury. Mol Med 17:293-307, 2011.
11. Reutershan J, Morris MA, Burcin TL, Smith DF, Chang D, Saprito S, Ley K: Critical role of endothelial cxcr2 in LPS-induced neutrophil migrations into the lung. J Clin Invest 116:695-702, 2006.
12. Yamamoto Y, Gaynor R: IkB kinases: key regulators of NF-kB pathway. Trends Biochem Sci 2:72-79. 2004.
13. Lemke G, Rothlin C: Immunobiology of the TAM receptors. Nat Rev Immunol 8:327-336, 2008.
14. Lee YJ, Han JY, Byun J, Park HJ, Park EM, Chong YH, Cho MS, Kang JL: Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and NF-. B activation and enhances inflammatory responses in lipopolysaccharideinduced acute lung injury. J Leukoc Biol 91:921-932, 2012.
15. Deng T, Zhang Y, Chen Q, Yan K, Han D: Toll-like receptorYmediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages. Immunology 135:40-50, 2012.
16. Fernandez-Fernandez L, Bellido-Martin L, Garcia de Frutos P: Growth arrest specific gene 6 (Gas6). An outline of its role in haemostasis and inflammation. Thromb Haemost 100:604-610, 2008.
17. Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jenette JC, Roubey RA, Earp HS, Masushima G, Reap EA: Delayed apoptotic clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 196:135-140, 2002.
18. Wu Y, Singh S, Georgescu MM, Birge RB: A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J Cell Sci 118: 539-553, 2005.
19. Hurtado B, de Frutos PG: Gas6 in systemic inflammatory disease: with and without infection. Crit Care 14:1003, 2010.
20. Giobt S, Massin F, Carvoisy A, Dupays R, Barraud D, Nace L, Bollaert PE: Growth arrestYspecific protein 6 plasma concentrations during septic shock. Crit Care 11:R8, 2007.
21. Ekman, C, Linder A, Akesson P, Dahlback B: Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes. Crit Care 14(4): R158, 2010.
22. O'Donnell K, Harkes IC, Dougherty L, Wicks IP: Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. Am J Pathol 154:1171-1180, 1999.
23. Shankar SL, O'Guin K, Kim M, Varnum B, Lemke G, Brosnan CF, Shafit-Zagardo B: Gas6/Axl signaling activates the phosphatidylserine 3-kinase/Akt1 survival pathway to protect oligodendrocytes from tumor necrosis factor alphaYinduced apoptosis. J Neurosci 26:5638-5648, 2006.
24. Hasanbasic I, Cuerguis J, Varnum B, Blostein MD: Intracellular signaling pathways involved in Gas6-Axl mediated survival of endothelial cells. Am J Physiol Hear Circ Physiol 287:1207-1213, 2004.
25. Llacun L, Barcena C, Bellido-Martin L, Fernandez L, Stefanovic M, Mari M, Garcia-Ruiz C, Fernandez-Checa JC, Garcia de Frutos P, Morales A: Growth arrestYspecific protein 6 is heptaoprotective against murine ischemia/reperfusion injury. Hepatology 52:1371-1379, 2010.
26. Png KJ, Halberg N, Yoshida M, Tavazoie SF: A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481:190-194, 2011.
27. Song X, Qian Y: The activation and regulation of IL-17 receptor mediated signaling. Thorax 62:175-182, 2013.
28. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, et al. : Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33:606-618, 2007.
29. Sharif MN, Sosic D, rothlin CV, Kelly E, Lemke G, Olson EN, Ivashkiv LB: Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 203:1891-1901, 2006.
30. Hotchkiss RS, Monneret G, Payen D: Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13:260-268, 2013.
31. Lemke G, Burstyn Cohen T: TAM receptors and the clearance of apoptotic cells. Ann N Y Acad Sci 1209:23-29, 2010.
32. Miksa M, Wu R, Dong W, Das P, Yang D, Wang P: Dendritic cellYderived exosomes containing milk fat globule epidermal growth factor VIII attenuate proinflammatory responses in sepsis. Shock 25:586-593, 2006.
33. Uriarte SM, Rane MJ, Merchant ML, Jin S, Lentsch AB, Ward RA, McLeish KR: Inhibition of neutrophil exocytosis ameliorates acute lung injury in rats. Shock 39:286-292, 2013.
34. Weinger JG, Omari KM, Marsden K, Raine CS, Shafit-Zagardo B: Upregulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions. Am J Pathol 175: 283-293, 2009.
35. Sather S, Kenyon KD, Lefkowitz JB, Liang X, Varnum B, Henson PM, Graham DK: A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 109: 1026-1033, 2007.